We are live on ! Find out more
LOAMS

Lombard Odier Asset Management (Switzerland) Portfolio holdings

AUM $2.63B
1-Year Est. Return 31.52%
This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+31.52%
3 Year Est. Return
+98.77%
5 Year Est. Return
+107.98%
10 Year Est. Return
+494.97%
AUM
$984M
AUM Growth
-$1.14M
Cap. Flow
-$27.8M
Cap. Flow %
-2.83%
Top 10 Hldgs %
25.61%
Holding
404
New
43
Increased
110
Reduced
106
Closed
68

Sector Composition

Rank Sector Weight
1 Healthcare 31.37%
2 Consumer Discretionary 18.24%
3 Consumer Staples 9.52%
4 Financials 8.75%
5 Industrials 5.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WU icon
376
Western Union
WU
$2.23B
-10,136
Closed -$187K
WY icon
377
Weyerhaeuser
WY
$17.8B
-16,611
Closed -$438K
WRK
378
DELISTED
WestRock Company
WRK
-10,878
Closed -$417K
ABMD
379
DELISTED
Abiomed Inc
ABMD
-22,500
Closed -$6.43M
DRE
380
DELISTED
Duke Realty Corp.
DRE
-7,645
Closed -$234K
BPYU
381
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
-36,829
Closed -$755K
TRQ
382
DELISTED
Turquoise Hill Resources Ltd
TRQ
-1,171
Closed -$19K
S
383
DELISTED
Sprint Corporation
S
-137,111
Closed -$775K

Similar funds

Lombard Odier Asset Management (Switzerland)'s Q2 2019 Portfolio in Review

As of Q2 2019, Lombard Odier Asset Management (Switzerland) held 404 positions worth $984M, down 0.12% from $986M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Lombard Odier Asset Management (Switzerland)'s Q2 2019 filing shows 43 new, 110 increased, 106 reduced and 68 closed positions. Its largest new stake was Apollo Global Management: 360,000 shares worth $12.3M. The largest sale was Pfizer, an estimated $21.9M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

  • Lombard Odier Asset Management (Switzerland)'s largest Q2 2019 buy was Apollo Global Management: 360,000 shares worth $12.3M.
  • Lombard Odier Asset Management (Switzerland) added most to Boston Scientific in Q2 2019, an estimated $12.3M increase.
  • Lombard Odier Asset Management (Switzerland)'s biggest Q2 2019 reduction was Pfizer, cutting an estimated $21.9M.
  • Lombard Odier Asset Management (Switzerland) fully exited Despegar.com in Q2 2019, selling an estimated $10.4M.
  • Lombard Odier Asset Management (Switzerland)'s ten largest holdings make up 26% of its $984M portfolio in Q2 2019.
  • Lombard Odier Asset Management (Switzerland) opened 43 new positions and closed 68 in Q2 2019.
  • Lombard Odier Asset Management (Switzerland)'s portfolio value fell 0.12% quarter-over-quarter to $984M.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2019, filed 14 Aug 2019.